$GCTK
GlucoTrack Inc Stock $gctk

$gctk Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000117891315002648 Filed on August 14, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$67.34K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$605.6K	$427.5K
YoY Change	41.64%	15.4%
% of Gross Profit
Research & Development	$558.0K	$454.8K
YoY Change	22.69%	-1.41%
% of Gross Profit
Depreciation & Amortization	$10.00K	$10.00K
YoY Change	0.0%
% of Gross Profit
Operating Expenses	$1.164M	$882.3K
YoY Change	31.87%	6.08%
Operating Profit	-$1.096M	-$882.3K
YoY Change	24.24%	6.08%
Interest Expense	-$570.0K	$6.140M
YoY Change	-109.28%	2261.54%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.670M	$5.260M
YoY Change	-131.75%	-1006.9%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$1.667M	$5.262M
YoY Change	-131.68%	-1012.58%
Net Earnings / Revenue	-2475.14%
Basic Earnings Per Share	-$0.33	$0.79
Diluted Earnings Per Share	-$0.33	$0.78
COMMON SHARES
Basic Shares Outstanding	5.441M shares	5.304M shares
Diluted Shares Outstanding	5.441M shares	5.336M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.520M	$590.0K
YoY Change	496.61%	-86.34%
Cash & Equivalents	$3.520M	$589.7K
Short-Term Investments
Other Short-Term Assets	$140.0K	$118.7K
YoY Change	17.98%	51.3%
Inventory	$140.0K
Prepaid Expenses
Receivables	$30.00K
Other Receivables	$0.00
Total Short-Term Assets	$3.820M	$708.4K
YoY Change	439.25%	-83.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$130.0K	$139.8K
YoY Change	-6.98%	52.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$210.0K	$170.0K
YoY Change	23.53%	0.0%
Total Long-Term Assets	$330.0K	$311.4K
YoY Change	5.97%	20.69%
TOTAL ASSETS
Total Short-Term Assets	$3.820M	$708.4K
Total Long-Term Assets	$330.0K	$311.4K
Total Assets	$4.150M	$1.020M
YoY Change	306.94%	-78.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$260.0K	$169.1K
YoY Change	53.71%	-3.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$790.0K	$517.1K
YoY Change	52.77%	-5.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$780.0K	$2.860M
YoY Change	-72.73%	2.14%
Total Long-Term Liabilities	$780.0K	$2.860M
YoY Change	-72.72%	2.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$790.0K	$517.1K
Total Long-Term Liabilities	$780.0K	$2.860M
Total Liabilities	$1.570M	$3.377M
YoY Change	-53.51%	0.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.52M	-$21.31M
YoY Change	24.43%	21.16%
Common Stock	$21.85M	$14.56M
YoY Change	50.05%	0.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.541M	-$6.714M
YoY Change
Total Liabilities & Shareholders Equity	$4.151M	$1.020M
YoY Change	307.01%	-78.1%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$1.667M	$5.262M
YoY Change	-131.68%	-1012.58%
Depreciation, Depletion And Amortization	$10.00K	$10.00K
YoY Change	0.0%
Cash From Operating Activities	-$1.240M	-$870.0K
YoY Change	42.53%	0.0%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	$40.00K
YoY Change	-75.0%	33.33%
Acquisitions
YoY Change
Other Investing Activities	-$20.00K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$30.00K	-$40.00K
YoY Change	-25.0%	-50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.00K	-120.0K
YoY Change	-75.0%	71.43%
NET CHANGE
Cash From Operating Activities	-1.240M	-870.0K
Cash From Investing Activities	-30.00K	-40.00K
Cash From Financing Activities	-30.00K	-120.0K
Net Change In Cash	-1.300M	-1.030M
YoY Change	26.21%	0.98%
FREE CASH FLOW
Cash From Operating Activities	-$1.240M	-$870.0K
Capital Expenditures	$10.00K	$40.00K
Free Cash Flow	-$1.250M	-$910.0K
YoY Change	37.36%	1.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1036305	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3145617	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1083762	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	863639	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2120067	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1769512	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1976900	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1769512	USD
	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	1224437	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3201337	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55720	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12147	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-91309	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	47036	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	185263	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-439939	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-486975	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-185263	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	54941	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-6898	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2311487	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1796175	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2385911	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	589736	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		USD
CY2015Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	45596	USD
CY2014Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7748685	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	5324	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	21852610	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	18182866	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	122390	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	66670	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26521231	USD
CY2015Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7121100	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23087063	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	-4540718	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-4832203	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4150697	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5323058	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5512867	shares
	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-6294521	USD
	us-gaap	Net Income Loss NetIncomeLoss	4525009	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-16033	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4508976	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5382682	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5303529	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.65
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5382682	shares
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	145388	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	118346	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	55720	USD
	igap	Adjustments To Additional Paid In Capital Investor Warrant Issued AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued	3413174	USD
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock		USD
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	47036	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12147	USD
	us-gaap	Depreciation Depreciation	18359	USD
	us-gaap	Depreciation Depreciation	16610	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	19854	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6293705	USD
	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	-1315	USD
	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion	-1270971	USD
	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion		USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3149	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	51036	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	24756	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	83030	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	83862	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1836282	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1556095	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18892	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47919	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-43171	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-47919	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	16459	USD
CY2015Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10459	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11637	USD
	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	-1872	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-38269	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3724	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	91309	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	6293705	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	8378	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	4223	USD
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5512867	shares
CY2015Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	81984	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	55557	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	Integrity Applications, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001506983
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
CY2013Q1	igap	Number Of Units Sold NumberOfUnitsSold	6300	shares
	igap	Number Of Units Sold NumberOfUnitsSold	8500	shares
CY2015Q2	us-gaap	Revenues Revenues	67342	USD
CY2014Q2	us-gaap	Revenues Revenues		USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	557980	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	454789	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	605565	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	427537	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	1163545	USD
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	882326	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1096203	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-882326	USD
CY2015Q2	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	570603	USD
CY2014Q2	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-6144254	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-1666806	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	5261928	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	97383	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-16905	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1569423	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5245023	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5441253	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5304072	shares
CY2014Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	-1003097	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3434168	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3497271	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1795886	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4166242	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted		USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	-842475	USD
CY2015Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted		USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5361570	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5441253	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5336019	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9367247	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3324535	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9537309	shares
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3369743	shares
	us-gaap	Dividends Stock DividendsStock		USD
	igap	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	58817	USD
	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-24279	USD
	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement		USD
CY2015Q2	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	1808	USD
CY2014Q2	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	3402	USD
CY2015Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-90872	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1757	USD
CY2015Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	25539	USD
CY2014Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	6147835	USD
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	5788	USD
CY2014Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1936	USD
CY2015Q2	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion	-497674	USD
CY2014Q2	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion		USD

Files In Submission

Name	View Source	Status
0001178913-15-002648-index-headers.html	Edgar Link	pending
0001178913-15-002648-index.html	Edgar Link	pending
0001178913-15-002648.txt	Edgar Link	pending
0001178913-15-002648-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
igap-20150630.xml	Edgar Link	completed
igap-20150630.xsd	Edgar Link	pending
igap-20150630_cal.xml	Edgar Link	unprocessable
igap-20150630_def.xml	Edgar Link	unprocessable
igap-20150630_lab.xml	Edgar Link	unprocessable
igap-20150630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1517195.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GCTK
GlucoTrack Inc Stock $gctk

2015 Q2 Form 10-Q Financial Statement

#000117891315002648 Filed on August 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK GlucoTrack Inc Stock $gctk

2015 Q2 Form 10-Q Financial Statement

#000117891315002648 Filed on August 14, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK
GlucoTrack Inc Stock $gctk